热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　石药集团（01093）盘中涨近3%，截至发稿，股价上涨1.31%，现报4.65港元，成交额5012.46万港元。

　　近日，石药集团公布，其附属公司巨石生物制药有限公司开发的SYS 6010（抗人EGFR人源化单抗–JS-1偶联注射剂）获中国国家药品监督管理局授予突破性治疗认定，拟定适应症为单药用于经EGFR-TKI和含铂化疗治疗失败的EGFR突变阳性晚期非小细胞肺癌（NSCLC）。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.